{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:51:01Z","timestamp":1773661861537,"version":"3.50.1"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T00:00:00Z","timestamp":1365724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s40259-013-0026-5","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T13:41:43Z","timestamp":1365687703000},"page":"281-291","source":"Crossref","is-referenced-by-count":22,"title":["Therapeutic Potential of Regulatory T cells in Autoimmune Disorders"],"prefix":"10.1007","volume":"27","author":[{"given":"Johannes","family":"Fessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Felber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Duftner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"issue":"10","key":"26_CR1","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.4049\/jimmunol.172.10.5967","volume":"172","author":"NA Danke","year":"2004","unstructured":"Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW. Autoreactive T cells in healthy individuals. J Immunol. 2004;172(10):5967\u201372.","journal-title":"J Immunol"},{"issue":"3","key":"26_CR2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","volume":"117","author":"C Dejaco","year":"2006","unstructured":"Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology. 2006;117(3):289\u2013300.","journal-title":"Immunology"},{"issue":"2","key":"26_CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.20020590","volume":"196","author":"CA Piccirillo","year":"2002","unstructured":"Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med. 2002;196(2):237\u201346.","journal-title":"J Exp Med"},{"issue":"4","key":"26_CR4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","volume":"178","author":"SG Zheng","year":"2007","unstructured":"Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+CD25\u2212 cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007;178(4):2018\u201327.","journal-title":"J Immunol"},{"issue":"1","key":"26_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20\u20131.","journal-title":"Nat Genet"},{"issue":"8","key":"26_CR6","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","volume":"110","author":"DQ Tran","year":"2007","unstructured":"Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood. 2007;110(8):2983\u201390.","journal-title":"Blood"},{"issue":"7","key":"26_CR7","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184(7):3433\u201341.","journal-title":"J Immunol"},{"issue":"8","key":"26_CR8","doi-asserted-by":"crossref","first-page":"e24226","DOI":"10.1371\/journal.pone.0024226","volume":"6","author":"T Akimova","year":"2011","unstructured":"Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS One. 2011;6(8):e24226.","journal-title":"PLoS One"},{"issue":"2","key":"26_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/eji.200324455","volume":"34","author":"AM Thornton","year":"2004","unstructured":"Thornton AM, Piccirillo CA, Shevach EM. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol. 2004;34(2):366\u201376.","journal-title":"Eur J Immunol"},{"issue":"5097","key":"26_CR10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.8094901","volume":"259","author":"S Qin","year":"1993","unstructured":"Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, et al. \u201cInfectious\u201d transplantation tolerance. Science. 1993;259(5097):974\u20137.","journal-title":"Science"},{"issue":"6","key":"26_CR11","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1084\/jem.183.6.2541","volume":"183","author":"TL Walunas","year":"1996","unstructured":"Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med. 1996;183(6):2541\u201350.","journal-title":"J Exp Med"},{"issue":"8","key":"26_CR12","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.172.8.4676","volume":"172","author":"N Misra","year":"2004","unstructured":"Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol. 2004;172(8):4676\u201380.","journal-title":"J Immunol"},{"issue":"4","key":"26_CR13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","volume":"21","author":"WJ Grossman","year":"2004","unstructured":"Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004;21(4):589\u2013601.","journal-title":"Immunity"},{"issue":"7169","key":"26_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450(7169):566\u20139.","journal-title":"Nature"},{"issue":"10","key":"26_CR15","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.4049\/jimmunol.0803646","volume":"182","author":"LW Collison","year":"2009","unstructured":"Collison LW, Pillai MR, Chaturvedi V, Vignali DA. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol. 2009;182(10):6121\u20138.","journal-title":"J Immunol"},{"issue":"11","key":"26_CR16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","volume":"10","author":"M Murai","year":"2009","unstructured":"Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol. 2009;10(11):1178\u201384.","journal-title":"Nat Immunol"},{"issue":"4","key":"26_CR17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28(4):546\u201358.","journal-title":"Immunity"},{"issue":"3","key":"26_CR18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4049\/jimmunol.170.3.1240","volume":"170","author":"A Sundstedt","year":"2003","unstructured":"Sundstedt A, O\u2019Neill EJ, Nicolson KS, Wraith DC. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol. 2003;170(3):1240\u20138.","journal-title":"J Immunol"},{"issue":"8","key":"26_CR19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","volume":"39","author":"RS Wildin","year":"2002","unstructured":"Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002;39(8):537\u201345.","journal-title":"J Med Genet"},{"issue":"10","key":"26_CR20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","volume":"45","author":"CA Lawson","year":"2006","unstructured":"Lawson CA, Brown AK, Bejarano V, Douglas SH, Burgoyne CH, Greenstein AS, et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford). 2006;45(10):1210\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"26_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004;200(3):277\u201385.","journal-title":"J Exp Med"},{"issue":"9","key":"26_CR22","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/art.20499","volume":"50","author":"JM Amelsfort van","year":"2004","unstructured":"van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004;50(9):2775\u201385.","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"26_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cellimm.2008.05.007","volume":"253","author":"GM Han","year":"2008","unstructured":"Han GM, O\u2019Neil-Andersen NJ, Zurier RB, Lawrence DA. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol. 2008;253(1\u20132):92\u2013101.","journal-title":"Cell Immunol"},{"issue":"2","key":"26_CR24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","volume":"140","author":"M Mottonen","year":"2005","unstructured":"Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O. CD4+CD25+T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol. 2005;140(2):360\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"26_CR25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1751-2980.2011.00505.x","volume":"12","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu XP, Zhao ZB, Chen JH, Yu CG. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease. J Dig Dis. 2011;12(4):286\u201394.","journal-title":"J Dig Dis"},{"issue":"9","key":"26_CR26","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.4049\/jimmunol.175.9.5591","volume":"175","author":"J Reddy","year":"2005","unstructured":"Reddy J, Waldner H, Zhang X, Illes Z, Wucherpfennig KW, Sobel RA, et al. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J Immunol. 2005;175(9):5591\u20135.","journal-title":"J Immunol"},{"issue":"7","key":"26_CR27","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.1001860","volume":"185","author":"AK Marwaha","year":"2010","unstructured":"Marwaha AK, Crome SQ, Panagiotopoulos C, Berg KB, Qin H, Ouyang Q, et al. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol. 2010;185(7):3814\u20138.","journal-title":"J Immunol"},{"issue":"6","key":"26_CR28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009;30(6):899\u2013911.","journal-title":"Immunity"},{"issue":"2","key":"26_CR29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2337\/db09-0694","volume":"59","author":"SA Long","year":"2010","unstructured":"Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes. 2010;59(2):407\u201315.","journal-title":"Diabetes"},{"issue":"5","key":"26_CR30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2337\/diabetes.54.5.1407","volume":"54","author":"TM Brusko","year":"2005","unstructured":"Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. Functional defects and the influence of age on the frequency of CD4+CD25+ T-cells in type 1 diabetes. Diabetes. 2005;54(5):1407\u201314.","journal-title":"Diabetes"},{"issue":"1","key":"26_CR31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2004.11.004","volume":"24","author":"AL Putnam","year":"2005","unstructured":"Putnam AL, Vendrame F, Dotta F, Gottlieb PA. CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun. 2005;24(1):55\u201362.","journal-title":"J Autoimmun"},{"issue":"7","key":"26_CR32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004;199(7):971\u20139.","journal-title":"J Exp Med"},{"issue":"1","key":"26_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","volume":"81","author":"J Huan","year":"2005","unstructured":"Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, et al. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res. 2005;81(1):45\u201352.","journal-title":"J Neurosci Res"},{"issue":"4","key":"26_CR34","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","volume":"178","author":"X Valencia","year":"2007","unstructured":"Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol. 2007;178(4):2579\u201388.","journal-title":"J Immunol"},{"issue":"2","key":"26_CR35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2249.2008.03686.x","volume":"153","author":"B Zhang","year":"2008","unstructured":"Zhang B, Zhang X, Tang F, Zhu L, Liu Y. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol. 2008;153(2):182\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"26_CR36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00439-005-0033-9","volume":"118","author":"S Han","year":"2005","unstructured":"Han S, Li Y, Mao Y, Xie Y. Meta-analysis of the association of CTLA-4 exon-1 +49A\/G polymorphism with rheumatoid arthritis. Hum Genet. 2005;118(1):123\u201332.","journal-title":"Hum Genet"},{"issue":"8","key":"26_CR37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.ejhg.5201214","volume":"12","author":"M Barreto","year":"2004","unstructured":"Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet. 2004;12(8):620\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"49","key":"26_CR38","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.0806855105","volume":"105","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci USA. 2008;105(49):19396\u2013401.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"26_CR39","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.182.3.1689","volume":"182","author":"M Bonelli","year":"2009","unstructured":"Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C. Phenotypic and functional analysis of CD4+CD25\u2212 Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol. 2009;182(3):1689\u201395.","journal-title":"J Immunol"},{"issue":"2","key":"26_CR40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2567.2008.02937.x","volume":"127","author":"JL Suen","year":"2009","unstructured":"Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology. 2009;127(2):196\u2013205.","journal-title":"Immunology"},{"issue":"6924","key":"26_CR41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421(6924):744\u20138.","journal-title":"Nature"},{"issue":"12","key":"26_CR42","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","volume":"198","author":"CA Murphy","year":"2003","unstructured":"Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198(12):1951\u20137.","journal-title":"J Exp Med"},{"issue":"3","key":"26_CR43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","volume":"127","author":"CK Wong","year":"2008","unstructured":"Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol. 2008;127(3):385\u201393.","journal-title":"Clin Immunol"},{"issue":"8","key":"26_CR44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","volume":"40","author":"M Aringer","year":"2001","unstructured":"Aringer M, Stummvoll GH, Steiner G, Koller M, Steiner CW, Hofler E, et al. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology (Oxford). 2001;40(8):876\u201381.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"26_CR45","first-page":"639","volume":"21","author":"I Gonzalez-Alvaro","year":"2003","unstructured":"Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuna R, Balsa A, Pascual-Salcedo D, Laffon A. Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease. Clin Exp Rheumatol. 2003;21(5):639\u201342.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"26_CR46","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","volume":"164","author":"M Ziolkowska","year":"2000","unstructured":"Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 2000;164(5):2832\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"26_CR47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.33418","volume":"64","author":"M Rossol","year":"2012","unstructured":"Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 2012;64(3):671\u20137.","journal-title":"Arthritis Rheum"},{"issue":"18","key":"26_CR48","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","volume":"113","author":"G Beriou","year":"2009","unstructured":"Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood. 2009;113(18):4240\u20139.","journal-title":"Blood"},{"issue":"1","key":"26_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","volume":"29","author":"XO Yang","year":"2008","unstructured":"Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29(1):44\u201356.","journal-title":"Immunity"},{"issue":"1","key":"26_CR50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.182.1.259","volume":"182","author":"G Lal","year":"2009","unstructured":"Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol. 2009;182(1):259\u201373.","journal-title":"J Immunol"},{"issue":"18","key":"26_CR51","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2009-05-219584","volume":"114","author":"G Lal","year":"2009","unstructured":"Lal G, Bromberg JS. Epigenetic mechanisms of regulation of Foxp3 expression. Blood. 2009;114(18):3727\u201335.","journal-title":"Blood"},{"issue":"4","key":"26_CR52","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","volume":"34","author":"S Huber","year":"2011","unstructured":"Huber S, Gagliani N, Esplugues E, O\u2019Connor W Jr, Huber FJ, Chaudhry A, et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity. 2011;34(4):554\u201365.","journal-title":"Immunity"},{"issue":"4","key":"26_CR53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10875-011-9527-5","volume":"31","author":"C Alvarez-Quiroga","year":"2011","unstructured":"Alvarez-Quiroga C, Abud-Mendoza C, Doniz-Padilla L, Juarez-Reyes A, Monsivais-Urenda A, Baranda L, et al. CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol. 2011;31(4):588\u201395.","journal-title":"J Clin Immunol"},{"issue":"7","key":"26_CR54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2310\/JIM.0b013e3181eb9895","volume":"58","author":"H Shen","year":"2010","unstructured":"Shen H, Xia L, Lu J, Xiao W. Infliximab reduces the frequency of interleukin 17-producing cells and the amounts of interleukin 17 in patients with rheumatoid arthritis. J Investig Med. 2010;58(7):905\u20138.","journal-title":"J Investig Med"},{"issue":"1","key":"26_CR55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ibd.21308","volume":"17","author":"G Boschetti","year":"2011","unstructured":"Boschetti G, Nancey S, Sardi F, Roblin X, Flourie B, Kaiserlian D. Therapy with anti-TNFalpha antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):160\u201370.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"26_CR56","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/rheumatology\/ker183","volume":"50","author":"C Blache","year":"2011","unstructured":"Blache C, Lequerre T, Roucheux A, Beutheu S, Dedreux I, Jacquot S, et al. Number and phenotype of rheumatoid arthritis patients\u2019 CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept. Rheumatology (Oxford). 2011;50(10):1814\u201322.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"26_CR57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/eye.2011.320","volume":"26","author":"S Calleja","year":"2012","unstructured":"Calleja S, Cordero-Coma M, Rodriguez E, Llorente M, Franco M, Ruiz de Morales JG. Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(\u2212) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study. Eye (Lond). 2012;26(3):468\u201377.","journal-title":"Eye (Lond)"},{"issue":"8","key":"26_CR58","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.34477","volume":"64","author":"M Samson","year":"2012","unstructured":"Samson M, Audia S, Janikashvili N, Ciudad M, Trad M, Fraszczak J, et al. Brief Report: Inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum. 2012;64(8):2499\u2013503.","journal-title":"Arthritis Rheum"},{"issue":"9789","key":"26_CR59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","volume":"378","author":"T Orban","year":"2011","unstructured":"Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):412\u20139.","journal-title":"Lancet"},{"issue":"Suppl 5","key":"26_CR60","doi-asserted-by":"crossref","first-page":"v22","DOI":"10.1093\/rheumatology\/kes115","volume":"51","author":"P Emery","year":"2012","unstructured":"Emery P. Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment. Rheumatology (Oxford). 2012;51(Suppl 5):v22\u201330.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"26_CR61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192(2):303\u201310.","journal-title":"J Exp Med"},{"issue":"5899","key":"26_CR62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008;322(5899):271\u20135.","journal-title":"Science"},{"issue":"12","key":"26_CR63","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","volume":"4","author":"F Fallarino","year":"2003","unstructured":"Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003;4(12):1206\u201312.","journal-title":"Nat Immunol"},{"key":"26_CR64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0105-2896.2006.00419.x","volume":"212","author":"DM Sansom","year":"2006","unstructured":"Sansom DM, Walker LS. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev. 2006;212:131\u201348.","journal-title":"Immunol Rev"},{"issue":"11","key":"26_CR65","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1002\/eji.200425143","volume":"34","author":"Q Tang","year":"2004","unstructured":"Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol. 2004;34(11):2996\u20133005.","journal-title":"Eur J Immunol"},{"key":"26_CR66","doi-asserted-by":"crossref","unstructured":"Huang B, Wang QT, Song SS, Wu YJ, Ma YK, Zhang LL, et al. Combined use of etanercept and MTX restores CD4(+)\/CD8 (+) ratio and Tregs in spleen and thymus in collagen-induced arthritis. Inflamm Res. 2012;61(11):1229\u201339.","DOI":"10.1007\/s00011-012-0520-0"},{"issue":"7192","key":"26_CR67","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","volume":"453","author":"L Zhou","year":"2008","unstructured":"Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008;453(7192):236\u201340.","journal-title":"Nature"},{"issue":"3","key":"26_CR68","first-page":"136","volume":"12","author":"B Prietl","year":"2010","unstructured":"Prietl B, Pilz S, Wolf M, Tomaschitz A, Obermayer-Pietsch B, Graninger W, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J. 2010;12(3):136\u20139.","journal-title":"Isr Med Assoc J"},{"issue":"23","key":"26_CR69","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832\u20138.","journal-title":"JAMA"},{"issue":"8","key":"26_CR70","doi-asserted-by":"crossref","first-page":"e6635","DOI":"10.1371\/journal.pone.0006635","volume":"4","author":"J Smolders","year":"2009","unstructured":"Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One. 2009;4(8):e6635.","journal-title":"PLoS One"},{"issue":"5","key":"26_CR71","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1186\/ar4060","volume":"14","author":"B Terrier","year":"2012","unstructured":"Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 2012;14(5):R221.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"26_CR72","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archpediatrics.2012.164","volume":"166","author":"MA Gabbay","year":"2012","unstructured":"Gabbay MA, Sato MN, Finazzo C, Duarte AJ, Dib SA. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual beta-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med. 2012;166(7):601\u20137.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"26_CR73","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","volume":"355","author":"G Suntharalingam","year":"2006","unstructured":"Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006;355(10):1018\u201328.","journal-title":"N Engl J Med"},{"issue":"6","key":"26_CR74","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","volume":"158","author":"L Chatenoud","year":"1997","unstructured":"Chatenoud L, Primo J, Bach JF. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol. 1997;158(6):2947\u201354.","journal-title":"J Immunol"},{"issue":"9790","key":"26_CR75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","volume":"378","author":"N Sherry","year":"2011","unstructured":"Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, et al. Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial. Lancet. 2011;378(9790):487\u201397.","journal-title":"Lancet"},{"issue":"1\u20132","key":"26_CR76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2008.07.027","volume":"274","author":"H Ochi","year":"2008","unstructured":"Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso A, et al. New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity. J Neurol Sci. 2008;274(1\u20132):9\u201312.","journal-title":"J Neurol Sci"},{"issue":"1","key":"26_CR77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10875-009-9323-7","volume":"30","author":"Y Ilan","year":"2010","unstructured":"Ilan Y, Zigmond E, Lalazar G, Dembinsky A, Ben Ya\u2019acov A, Hemed N, et al. Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells. J Clin Immunol. 2010;30(1):167\u201377.","journal-title":"J Clin Immunol"},{"issue":"1","key":"26_CR78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.25058","volume":"62","author":"CA Notley","year":"2010","unstructured":"Notley CA, McCann FE, Inglis JJ, Williams RO. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis. Arthritis Rheum. 2010;62(1):171\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"26_CR79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","volume":"164","author":"AM Thornton","year":"2000","unstructured":"Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164(1):183\u201390.","journal-title":"J Immunol"},{"issue":"11","key":"26_CR80","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","volume":"199","author":"Q Tang","year":"2004","unstructured":"Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med. 2004;199(11):1455\u201365.","journal-title":"J Exp Med"},{"issue":"2","key":"26_CR81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mt.2009.197","volume":"18","author":"D Bresson","year":"2010","unstructured":"Bresson D, Fradkin M, Manenkova Y, Rottembourg D, von Herrath M. Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3\/GAD65 combination therapy in new-onset type 1 diabetes. Mol Ther. 2010;18(2):307\u201316.","journal-title":"Mol Ther"},{"issue":"3","key":"26_CR82","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diabetes.51.3.638","volume":"51","author":"A Rabinovitch","year":"2002","unstructured":"Rabinovitch A, Suarez-Pinzon WL, Shapiro AM, Rajotte RV, Power R. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes. 2002;51(3):638\u201345.","journal-title":"Diabetes"},{"issue":"8","key":"26_CR83","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood-2010-10-313684","volume":"118","author":"HJ Shin","year":"2011","unstructured":"Shin HJ, Baker J, Leveson-Gower DB, Smith AT, Sega EI, Negrin RS. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood. 2011;118(8):2342\u201350.","journal-title":"Blood"},{"issue":"1","key":"26_CR84","doi-asserted-by":"crossref","first-page":"e15868","DOI":"10.1371\/journal.pone.0015868","volume":"6","author":"TN Golovina","year":"2011","unstructured":"Golovina TN, Mikheeva T, Brusko TM, Blazar BR, Bluestone JA, Riley JL. Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS One. 2011;6(1):e15868.","journal-title":"PLoS One"},{"key":"26_CR85","doi-asserted-by":"crossref","unstructured":"Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, et al. Rapamycin\/IL-2 Combination Therapy in Patients with Type 1 Diabetes Augments Tregs yet Transiently Impairs beta-Cell Function. Diabetes. 2012;61(9):2340\u20138.","DOI":"10.2337\/db12-0049"},{"issue":"4","key":"26_CR86","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaut.2011.10.001","volume":"37","author":"D Bresson","year":"2011","unstructured":"Bresson D, Fousteri G, Manenkova Y, Croft M, von Herrath M. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment. J Autoimmun. 2011;37(4):342\u201351.","journal-title":"J Autoimmun"},{"issue":"7","key":"26_CR87","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/blood-2004-07-2959","volume":"105","author":"B Valzasina","year":"2005","unstructured":"Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP. Triggering of OX40 (CD134) on CD4(+)CD25\u00a0+\u00a0T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood. 2005;105(7):2845\u201351.","journal-title":"Blood"},{"issue":"7","key":"26_CR88","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood-2007-01-070748","volume":"110","author":"MD Vu","year":"2007","unstructured":"Vu MD, Xiao X, Gao W, Degauque N, Chen M, Kroemer A, et al. OX40 costimulation turns off Foxp3+ Tregs. Blood. 2007;110(7):2501\u201310.","journal-title":"Blood"},{"issue":"5","key":"26_CR89","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2007.086066","volume":"68","author":"H Kelchtermans","year":"2009","unstructured":"Kelchtermans H, Geboes L, Mitera T, Huskens D, Leclercq G, Matthys P. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann Rheum Dis. 2009;68(5):744\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"26_CR90","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","volume":"52","author":"ME Morgan","year":"2005","unstructured":"Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 2005;52(7):2212\u201321.","journal-title":"Arthritis Rheum"},{"key":"26_CR91","doi-asserted-by":"crossref","unstructured":"Marek-Trzonkowska N, Mysliwiec M, Dobyszuk A, Grabowska M, Techmanska I, Juscinska J, et al. Administration of CD4+CD25highCD127\u2212 regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care. 2012;35(9):1817\u201320.","DOI":"10.2337\/dc12-0038"},{"key":"26_CR92","doi-asserted-by":"crossref","unstructured":"Kong N, Lan Q, Chen M, Wang J, Shi W, Horwitz DA, et al. Antigen-specific TGF-beta-induced regulatory T cells but not natural Tregs ameliorate autoimmune arthritis by shifting the balance of Th17 toward Treg cells. Arthritis Rheum. 2012;64(8):2548\u201358.","DOI":"10.1002\/art.34513"},{"issue":"1","key":"26_CR93","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.immuni.2011.03.029","volume":"35","author":"D Haribhai","year":"2011","unstructured":"Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity. 2011;35(1):109\u201322.","journal-title":"Immunity"},{"key":"26_CR94","doi-asserted-by":"crossref","unstructured":"Jeon EJ, Yoon BY, Lim JY, Oh HJ, Park HS, Park MJ, et al. Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model. Autoimmunity. 2012;45(6):460\u20139.","DOI":"10.3109\/08916934.2012.682666"},{"issue":"4","key":"26_CR95","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330\u20136.","journal-title":"Nat Immunol"},{"issue":"4","key":"26_CR96","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4(4):337\u201342.","journal-title":"Nat Immunol"},{"issue":"5609","key":"26_CR97","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057\u201361.","journal-title":"Science"},{"issue":"9","key":"26_CR98","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/art.22846","volume":"56","author":"J Ohata","year":"2007","unstructured":"Ohata J, Miura T, Johnson TA, Hori S, Ziegler SF, Kohsaka H. Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts. Arthritis Rheum. 2007;56(9):2947\u201356.","journal-title":"Arthritis Rheum"},{"issue":"45","key":"26_CR99","doi-asserted-by":"crossref","first-page":"19078","DOI":"10.1073\/pnas.0907396106","volume":"106","author":"GP Wright","year":"2009","unstructured":"Wright GP, Notley CA, Xue SA, Bendle GM, Holler A, Schumacher TN, et al. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc Natl Acad Sci USA. 2009;106(45):19078\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR100","doi-asserted-by":"crossref","unstructured":"Liu X, Xu X, Lin X, Tian Y, Ji B, Xia S, et al. PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+) CD25(\u2212) T cells to regulatory T-like cells. J Cell Biochem. 2012;113(12):3797\u2013809.","DOI":"10.1002\/jcb.24255"},{"issue":"7","key":"26_CR101","doi-asserted-by":"crossref","first-page":"e11726","DOI":"10.1371\/journal.pone.0011726","volume":"5","author":"TM Brusko","year":"2010","unstructured":"Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, et al. Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. PLoS One. 2010;5(7):e11726.","journal-title":"PLoS One"},{"issue":"7","key":"26_CR102","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.4049\/jimmunol.166.7.4312","volume":"166","author":"S Corinti","year":"2001","unstructured":"Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol. 2001;166(7):4312\u20138.","journal-title":"J Immunol"},{"issue":"4","key":"26_CR103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm.1925","volume":"15","author":"S Manicassamy","year":"2009","unstructured":"Manicassamy S, Ravindran R, Deng J, Oluoch H, Denning TL, Kasturi SP, et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med. 2009;15(4):401\u20139.","journal-title":"Nat Med"},{"issue":"9","key":"26_CR104","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.1772","volume":"10","author":"JM Ilarregui","year":"2009","unstructured":"Ilarregui JM, Croci DO, Bianco GA, Toscano MA, Salatino M, Vermeulen ME, et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol. 2009;10(9):981\u201391.","journal-title":"Nat Immunol"},{"issue":"1","key":"26_CR105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/art.30099","volume":"63","author":"F Arce","year":"2011","unstructured":"Arce F, Breckpot K, Stephenson H, Karwacz K, Ehrenstein MR, Collins M, et al. Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis. Arthritis Rheum. 2011;63(1):84\u201395.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"26_CR106","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2002-10-3229","volume":"101","author":"K Mahnke","year":"2003","unstructured":"Mahnke K, Qian Y, Knop J, Enk AH. Induction of CD4+\/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 2003;101(12):4862\u20139.","journal-title":"Blood"},{"issue":"6","key":"26_CR107","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","volume":"194","author":"D Hawiger","year":"2001","unstructured":"Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194(6):769\u201379.","journal-title":"J Exp Med"},{"issue":"21","key":"26_CR108","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1073\/pnas.0900621106","volume":"106","author":"M Ayyoub","year":"2009","unstructured":"Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, Bioley G, et al. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci USA. 2009;106(21):8635\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"26_CR109","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S Floess","year":"2007","unstructured":"Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007;5(2):e38.","journal-title":"PLoS Biol"},{"issue":"3","key":"26_CR110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/icb.2008.106","volume":"87","author":"L Wang","year":"2009","unstructured":"Wang L, Tao R, Hancock WW. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. Immunol Cell Biol. 2009;87(3):195\u2013202.","journal-title":"Immunol Cell Biol"},{"key":"26_CR111","doi-asserted-by":"crossref","unstructured":"Ju JH, Heo YJ, Cho ML, Jhun JY, Park JS, Oh HJ, et al. Modulation of STAT3 in rheumatoid Synovial T cells suppresses Th17 differentiation and increases the proportion of regulatory T cells. Arthritis Rheum. 2012;64(11):3543\u201352.","DOI":"10.1002\/art.34601"},{"issue":"5","key":"26_CR112","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db07-1460","volume":"57","author":"MJ Richer","year":"2008","unstructured":"Richer MJ, Straka N, Fang D, Shanina I, Horwitz MS. Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta. Diabetes. 2008;57(5):1302\u201311.","journal-title":"Diabetes"},{"issue":"2","key":"26_CR113","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20040298","volume":"200","author":"S Mendez","year":"2004","unstructured":"Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med. 2004;200(2):201\u201310.","journal-title":"J Exp Med"},{"issue":"5","key":"26_CR114","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/hep.20454","volume":"40","author":"R Cabrera","year":"2004","unstructured":"Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 2004;40(5):1062\u201371.","journal-title":"Hepatology"},{"key":"26_CR115","doi-asserted-by":"crossref","unstructured":"Pedroza-Gonzalez A, Verhoef C, Ijzermans JN, Peppelenbosch MP, Kwekkeboom J, Verheij J, et al. Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. Hepatology. 2013;57(1):183\u201394.","DOI":"10.1002\/hep.26013"},{"issue":"7","key":"26_CR116","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/IGC.0b013e318262aa53","volume":"22","author":"S Adurthi","year":"2012","unstructured":"Adurthi S, Mukherjee G, Krishnamurthy H, Sudhir K, Bafna UD, Umadevi K, et al. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells. Int J Gynecol Cancer. 2012;22(7):1130\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"26_CR117","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1073\/pnas.0811556106","volume":"106","author":"N Komatsu","year":"2009","unstructured":"Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA. 2009;106(6):1903\u20138.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-013-0026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40259-013-0026-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-013-0026-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T23:30:43Z","timestamp":1688167843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40259-013-0026-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s40259-013-0026-5","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,12]]}}}